UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

The q-Theory Approach to Understanding the Accrual Anomaly

Journal of accounting research, 2010-03, Vol.48 (1), p.177-223

2010

Volltextzugriff (PDF)

Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo

The Journal of biological chemistry, 2015-08, Vol.290 (33), p.20044-20059

2015

Volltextzugriff (PDF)

Activation of the human insulin receptor by non-insulin-related peptides

Nature communications, 2022-09, Vol.13 (1), p.5695-5695, Article 5695

2022

Volltextzugriff (PDF)

A Framework for Exploring the Macroeconomic Determinants of Systematic Risk

The American economic review, 2005-05, Vol.95 (2), p.398-404

2005

Volltextzugriff (PDF)

Crystallographic Structures of the Ligand-Binding Domains of the Androgen Receptor and Its T877A Mutant Complexed with the Natural Agonist Dihydrotestosterone

Proceedings of the National Academy of Sciences - PNAS, 2001-04, Vol.98 (9), p.4904-4909

2001

Volltextzugriff (PDF)

Position 5.46 of the Serotonin 5-HT2A Receptor Contributes to a Species-Dependent Variation for the 5-HT2C Agonist (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: Impact on Selectivity and Toxicological Evaluation

Molecular pharmacology, 2009-12, Vol.76 (6), p.1211

2009

Volltextzugriff (PDF)

Do Anomalies Exist Ex Ante?

Review of Finance, 2014-07, Vol.18 (3), p.843-875

2014

Volltextzugriff (PDF)

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5‑HT2C Receptor Agonists

Journal of medicinal chemistry, 2017-07, Vol.60 (14), p.6166-6190

2017

Volltextzugriff (PDF)

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT 2C Receptor Agonists

Journal of medicinal chemistry, 2017-07, Vol.60 (14), p.6166-6190

2017

Volltextzugriff (PDF)

Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists

Bioorganic & medicinal chemistry letters, 2013-01, Vol.23 (1), p.330-335

2013

Volltextzugriff (PDF)

Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists

Bioorganic & medicinal chemistry letters, 2013-07, Vol.23 (13), p.3914-3919

2013

Volltextzugriff (PDF)

Discovery of ( R )-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1- a ]isoindol- 6(2 H )-one, a Selective, Orally Active Agonist of the 5-HT 2C Receptor

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1365-1379

2007

Volltextzugriff (PDF)

Tricyclic dihydroquinazolinones as novel 5-HT2c selective and orally efficacious anti-obesity agents

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.1128-1133

2010

Volltextzugriff (PDF)

Position 5.46 of the Serotonin 5-HT 2A Receptor Contributes to a Species-Dependent Variation for the 5-HT 2C Agonist ( R )-9-Ethyl-1,3,4,10 b -tetrahydro-7-trifluoromethylpyrazino[2,1- a ]isoindol-6(2 H )-one: Impact on Selectivity and Toxicological Evaluation

Molecular pharmacology, 2009-12, Vol.76 (6), p.1211-1219

2009

Volltextzugriff (PDF)

Realized Beta: Persistence and Predictability

Econometric Analysis of Financial and Economic Time Series, 2006, Vol.20 Part 2, p.1-39

2006

Volltextzugriff (PDF)

Tricyclic dihydroquinazolinones as novel 5-HT sub(2C) selective and orally efficacious anti-obesity agents

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.1128-1133

2010

Volltextzugriff (PDF)

Tricyclic dihydroquinazolinones as novel 5-HT 2C selective and orally efficacious anti-obesity agents

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (3), p.1128-1133

2010

Volltextzugriff (PDF)

FINANCIAL ECONOMICS, MACROECONOMICS, AND ECONOMETRICS: THE INTERFACE[dagger]: A Framework for Exploring the Macroeconomic Determinants of Systematic Risk

The American economic review, 2005-05, Vol.95 (2), p.398

2005

Volltextzugriff (PDF)

Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT(2C) receptor agonists

Bioorganic & medicinal chemistry letters, 2013-07, Vol.23 (13), p.3914-3919

2013

Volltextzugriff (PDF)

Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1365-1379

2007

Volltextzugriff (PDF)

Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1365-1379

2007

Volltextzugriff (PDF)

A Framework for Exploring the Macroeconomic Determinants of Systematic Risk

NBER Working Paper Series, 2005-02, p.11134

2005

Volltextzugriff (PDF)

Essays on financial economics and econometrics

Wu, Jin (Ginger)

2005

Volltextzugriff (PDF)

Does Risk Explain Anomalies? Evidence from Expected Return Estimates

NBER Working Paper Series, 2010-04, p.15950

2010

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(54)
Humans
(46)
Male
(22)
Animals
(21)
Female
(18)
Physical Sciences
(15)
Biological And Medical Sciences
(13)
Mice
(13)
Aged
(12)
Biochemistry & Molecular Biology
(12)
Medical Sciences
(11)
Pharmacology & Pharmacy
(11)
Science & Technology - Other Topics
(11)
Chemistry
(10)
Middle Aged
(10)
Rats
(10)
Chemistry, Medicinal
(9)
Adult
(8)
Medical Research
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The q-Theory Approach to Understanding the Accrual Anomaly

Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo

Activation of the human insulin receptor by non-insulin-related peptides

A Framework for Exploring the Macroeconomic Determinants of Systematic Risk

Crystallographic Structures of the Ligand-Binding Domains of the Androgen Receptor and Its T877A Mutant Complexed with the Natural Agonist Dihydrotestosterone

Position 5.46 of the Serotonin 5-HT2A Receptor Contributes to a Species-Dependent Variation for the 5-HT2C Agonist (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: Impact on Selectivity and Toxicological Evaluation

Do Anomalies Exist Ex Ante?

Discovery of 5‑Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)‑one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5‑HT2C Receptor Agonists

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT 2C Receptor Agonists

Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists

Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists

Discovery of ( R )-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1- a ]isoindol- 6(2 H )-one, a Selective, Orally Active Agonist of the 5-HT 2C Receptor

Tricyclic dihydroquinazolinones as novel 5-HT2c selective and orally efficacious anti-obesity agents

Position 5.46 of the Serotonin 5-HT 2A Receptor Contributes to a Species-Dependent Variation for the 5-HT 2C Agonist ( R )-9-Ethyl-1,3,4,10 b -tetrahydro-7-trifluoromethylpyrazino[2,1- a ]isoindol-6(2 H )-one: Impact on Selectivity and Toxicological Evaluation

Realized Beta: Persistence and Predictability

Tricyclic dihydroquinazolinones as novel 5-HT sub(2C) selective and orally efficacious anti-obesity agents

Tricyclic dihydroquinazolinones as novel 5-HT 2C selective and orally efficacious anti-obesity agents

FINANCIAL ECONOMICS, MACROECONOMICS, AND ECONOMETRICS: THE INTERFACE[dagger]: A Framework for Exploring the Macroeconomic Determinants of Systematic Risk

Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT(2C) receptor agonists

Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor

Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor

A Framework for Exploring the Macroeconomic Determinants of Systematic Risk

Essays on financial economics and econometrics

Does Risk Explain Anomalies? Evidence from Expected Return Estimates

Suchergebnisse filtern